To characterize where IgG response to COVID-19 mRNA vaccine develops, RBD-specific B cells were enumerated in the circulation of vaccinated patients and their expression of CD21, CD11c, CD27 and IgD was determined by flow cytometry (Fig. 4, A to C). The gene discussed is CR2; the disease is COVID-19.